Minnesota SF2075 mandates health plans to cover obesity management and treatment, including behavioral therapy, surgery, and FDA-approved medications.
Minnesota SF2075 requires health plans to cover the management and treatment of obesity, including intensive health behavior and lifestyle treatment, metabolic and bariatric surgery, and FDA-approved obesity medication. The bill mandates that coverage criteria for FDA-approved obesity medications must not be more restrictive than the FDA-approved indications. The coverage must be consistent with other illnesses, conditions, or disorders for deductibles, co-payments, and coinsurance. The bill is effective January 1, 2027, for health plans offered, issued, or renewed on or after that date.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.